Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2331-2021Class II

AltiVate Anatomic Shoulder System for the following Part Numbers: 1. Part # 520-08-00, Rev. C., 2. Part #...

Encore Medical, LP / initiated 2021-06-28 / Open, Classified

Encore Medical, LP began a recall of AltiVate Anatomic Shoulder System for the following Part Numbers: 1. Part # 520-08-00, Rev. C., 2. Part # 520-10-000, 3. Part # 520-12-000, 4. Part #... on . FDA classified it as Class II and gives the reason as "Complaints have been received concerning the humeral stem failing to mate with the broach handles for a shoulder device. This could result in delay of procedure or revision surgery". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2331-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Encore Medical, LP
Product
AltiVate Anatomic Shoulder System for the following Part Numbers: 1. Part # 520-08-00, Rev. C., 2. Part # 520-10-000, 3. Part # 520-12-000, 4. Part # 520-14-000, 5. Part # 520-16-000
Product code
KWS Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented
Reason for recall
Complaints have been received concerning the humeral stem failing to mate with the broach handles for a shoulder device. This could result in delay of procedure or revision surgery.
FDA root cause
Process change control
Action
On June 28, 2021, Encore Medical (DJO) issued a "Urgent Medical Device Recall" Notification to affected consignees, via E-Mail. In addition to informing consignees about the recall devices, the firm asked consignees to take the following actions by July 19, 2021: 1. Review your stock for the affected products and lot numbers and quarantine the items until returned. 2. Communicate the affected parts, lots, and quantities that you have in stock to your sales Agent and arrange to return all affected, unused product to your sales Agent. 3. Report any adverse events related to this issue to DJO Customer Service (1-800-456-8696). Please also note that Adverse reactions or quality problems experienced with the use of this product MAY be reported to the FDAs MedWatch Adverse Event reporting program either online, by regular mail or by fax. 4. Complete the Medical Device Recall acknowledge and receipt form (including all information in the yellow-highlighted cells) with all available information and return by e-mail to [email protected] and [email protected] by July 31, 2021.
Distribution
US: AL,AR,AZ,CA,CO,FL,GA,HI,IL,IN,KY,LA,MD,ME,MI,MN,MO,MS,MT,NM,NV,NY,OH,OK,OR,PA,PR,RI,SC,TN,TX,UT,VA,WA,WV OUS: N/A
Product codes and lots
Part number/ Lot number:   1. 520-08-000 / 85OU1108; 85OU1110; 85OU1111,  2. 520-10-000 / 851U1256; 851U1257; 851U1258; 851U1259,  3. 520-12-000 / 852U1402; 852U1393; 852U1404; 852U1395; 852U1398A, 852U1405; 852U1397; 852U1391; 852U1400; 852U1398; 852U1407; 852U1396; 852U1406,  4. 520-14-000 / 853U1234; 853U1240; 853U1241A; 853U1238; 853U1239; 853U1237; 853U1241,  5. 520-16-000 / 854U1076; 854U1077

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2331-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2331-2021Class IIOngoingVoluntary: Firm initiated